Literature DB >> 11301032

Visual cycle impairment in cellular retinaldehyde binding protein (CRALBP) knockout mice results in delayed dark adaptation.

J C Saari1, M Nawrot, B N Kennedy, G G Garwin, J B Hurley, J Huang, D E Possin, J W Crabb.   

Abstract

Mutations in the human CRALBP gene cause retinal pathology and delayed dark adaptation. Biochemical studies have not identified the primary physiological function of CRALBP. To resolve this, we generated and characterized mice with a non-functional CRALBP gene (Rlbp1(-/-) mice). The photosensitivity of Rlbp1(-/-) mice is normal but rhodopsin regeneration, 11-cis-retinal production, and dark adaptation after illumination are delayed by >10-fold. All-trans-retinyl esters accumulate during the delay indicating that isomerization of all-trans- to 11-cis-retinol is impaired. No evidence of photoreceptor degeneration was observed in animals raised in cyclic light/dark conditions for up to 1 year. Albino Rlbp(-/-) mice are protected from light damage relative to the wild type. These findings support a role for CRALBP as an acceptor of 11-cis-retinol in the isomerization reaction of the visual cycle.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11301032     DOI: 10.1016/s0896-6273(01)00248-3

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  93 in total

Review 1.  Recent advances in the dark adaptation investigations.

Authors:  Guo-Qing Yang; Tao Chen; Ye Tao; Zuo-Ming Zhang
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

2.  Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle.

Authors:  T Michael Redmond; Eugenia Poliakov; Shirley Yu; Jen-Yue Tsai; Zhongjian Lu; Susan Gentleman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-06       Impact factor: 11.205

3.  Molecular properties of rhodopsin and rod function.

Authors:  Hiroo Imai; Vladimir Kefalov; Keisuke Sakurai; Osamu Chisaka; Yoshiki Ueda; Akishi Onishi; Takefumi Morizumi; Yingbin Fu; Kazuhisa Ichikawa; Kei Nakatani; Yoshihito Honda; Jeannie Chen; King-Wai Yau; Yoshinori Shichida
Journal:  J Biol Chem       Date:  2006-12-28       Impact factor: 5.157

Review 4.  Two-photon microscopy: shedding light on the chemistry of vision.

Authors:  Yoshikazu Imanishi; Kerrie H Lodowski; Yiannis Koutalos
Journal:  Biochemistry       Date:  2007-08-03       Impact factor: 3.162

Review 5.  [Genetic diseases of the retinal pigment epithelium].

Authors:  M N Preising; B Lorenz
Journal:  Ophthalmologe       Date:  2009-04       Impact factor: 1.059

6.  Formation of all-trans retinol after visual pigment bleaching in mouse photoreceptors.

Authors:  Chunhe Chen; Lorie R Blakeley; Yiannis Koutalos
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-05       Impact factor: 4.799

Review 7.  Retinal light damage: mechanisms and protection.

Authors:  Daniel T Organisciak; Dana K Vaughan
Journal:  Prog Retin Eye Res       Date:  2009-12-03       Impact factor: 21.198

8.  Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics.

Authors:  Artur V Cideciyan; Tomas S Aleman; Sanford L Boye; Sharon B Schwartz; Shalesh Kaushal; Alejandro J Roman; Ji-Jing Pang; Alexander Sumaroka; Elizabeth A M Windsor; James M Wilson; Terence R Flotte; Gerald A Fishman; Elise Heon; Edwin M Stone; Barry J Byrne; Samuel G Jacobson; William W Hauswirth
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-22       Impact factor: 11.205

9.  Genetic and phenotypic analysis of Tcm, a mutation affecting early eye development.

Authors:  Ken S Wang; Lauren E Zahn; Jack Favor; Kristen M Huang; Dwight Stambolian
Journal:  Mamm Genome       Date:  2005-05       Impact factor: 2.957

Review 10.  Structural biology of 11-cis-retinaldehyde production in the classical visual cycle.

Authors:  Anahita Daruwalla; Elliot H Choi; Krzysztof Palczewski; Philip D Kiser
Journal:  Biochem J       Date:  2018-10-22       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.